MedPath

RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis

Phase 1
Terminated
Conditions
Psychosis
Schizophrenia
Schizoaffective Disorder
Interventions
Drug: Normal Saline
First Posted Date
2008-01-11
Last Posted Date
2022-12-02
Lead Sponsor
Research Foundation for Mental Hygiene, Inc.
Target Recruit Count
12
Registration Number
NCT00591318
Locations
🇺🇸

NYS Psychiatric Institute, New York, New York, United States

Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia

Phase 4
Completed
Conditions
Schizophrenia
Interventions
First Posted Date
2007-06-20
Last Posted Date
2017-10-05
Lead Sponsor
Research Foundation for Mental Hygiene, Inc.
Target Recruit Count
20
Registration Number
NCT00488163
Locations
🇺🇸

Mount Sinai Hospital, New York, New York, United States

🇺🇸

Pilgrim Psychiatric Center, Brentwood, New York, United States

Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia

Phase 4
Conditions
Schizophrenia
Schizoaffective Disorder
Cognitive Impairment
First Posted Date
2007-05-04
Last Posted Date
2008-05-21
Lead Sponsor
Research Foundation for Mental Hygiene, Inc.
Target Recruit Count
50
Registration Number
NCT00469664
Locations
🇺🇸

Mount Sinai Medical Center, NY, New York, United States

🇺🇸

Bronx VA Medical Center, Bronx, New York, United States

🇺🇸

Pilgrim Psychiatric Center, W. Brentwood, New York, United States

Reducing Unsafe Alcohol Use in HIV-Positive Individuals

Not Applicable
Completed
Conditions
Alcohol Abuse
Interventions
Behavioral: Enhanced Motivational Interview
Behavioral: Standard Motivational Interview or viewing DVD
First Posted Date
2006-09-04
Last Posted Date
2015-10-30
Lead Sponsor
Research Foundation for Mental Hygiene, Inc.
Target Recruit Count
254
Registration Number
NCT00371969
Locations
🇺🇸

New York State Psychiatric Institute/ St. Vincent's Hospital, New York, New York, United States

A Placebo-Controlled Double-Blind Combined Treatment of Modafinil and CBT for Cocaine Dependence

Phase 2
Completed
Conditions
Cocaine Dependence
Interventions
Behavioral: Cognitive Behavioral Therapy--Relapse Prevention
First Posted Date
2006-06-27
Last Posted Date
2012-12-03
Lead Sponsor
Research Foundation for Mental Hygiene, Inc.
Target Recruit Count
15
Registration Number
NCT00344565
© Copyright 2025. All Rights Reserved by MedPath